"The drug, called LOY-002, mimics the beneficial effects of calorie restriction without having to put your senior pooch on a strict diet."
"At the end of that, we will hopefully see that the dogs on the drug are living longer, they have less frailty, they have a better quality of life, hopefully they have less age-related disease."
"The team behind the pill said they want owners to be able to take a proactive approach while their dog is healthy, rather than waiting for ageing to damage the dog's health."
"The FDA recognizes that studies like this are long. They take years and years to run."
A startup in San Francisco is developing a chewable pill, LOY-002, for older dogs to potentially extend their lifespan by at least a year. The drug targets metabolic dysfunction, a key factor in aging-related diseases. Over 1,300 dogs are enrolled in the study named 'STAY', which monitors the effects of the drug versus a placebo. The goal is to improve quality of life and reduce age-related diseases. The FDA has granted safety approval, allowing potential early availability of the drug.
Read at Mail Online
Unable to calculate read time
Collection
[
|
...
]